Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Meeting Customer Needs
J
James E. Gregory
President & CEO
UPM Pharmaceuticals
Apr 20, 2017
PTV-M01-17-NS-014
CDMO
OSD
PA TV (video)
James E. Gregory, President and CEO, UPM Pharmaceuticals
STAGING
Related Content
Orthogonal Methods
Orthogonal Analytics: How Much Characterization Is Enough?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-14
Oct 22, 2026
SmartScale
Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model
Jesse McCool, Ph.D.
GBI Biomanufacturing
PAO-10-26-CL-05
Oct 21, 2026
Data-Driven Mfg
Data-Driven Manufacturing and Digital Twins Across the Biologics Network
Jihyeon Oh; Hongwoo Joo
Samsung Biologics
PAO-10-26-CL-03
Oct 21, 2026
Flow Chemistry
When Flow Chemistry Solves the Manufacturing Problem
Hiroaki Yasukouchi, Ph.D.
Kaneka
PAO-10-26-CL-04
Oct 20, 2026
ASDs
The Evolving Science of Amorphous Solid Dispersions
Pharma's Almanac
PAO-10-26-PA-13
Oct 20, 2026
CLD
Can Mammalian Cell-Line Engineering Become a High-Throughput Design Problem?
Pharma's Almanac
PAO-10-26-PA-09
Oct 14, 2026
Bioprocessing
Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-06
Oct 9, 2026
Pathfinder
Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?
Nice Insight
PAO-26-PF-28
Oct 9, 2026
Formulation Models
Predictive Formulation: Can Modeling Reduce Empirical Development?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-04
Oct 7, 2026
Pathfinder
Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?
Nice Insight
PAO-26-PF-27
Oct 2, 2026
Viral CDMO
Choosing a CDMO That Can Grow with a Viral Program
Kai Lipinski, Ph.D.
Recipharm Advanced Bio
PAO-09-26-CL-08
Oct 1, 2026
Viral Vectors
Gene Therapy Manufacturing After the Capacity Boom
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-01
Oct 1, 2026
Previous slide
Next slide